Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,493,830
+$28,118,631 QoQ
Shares Held
807,316
+13.2% QoQ
Ownership
2.77%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#8
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Derivatives in ANAB
reported options exposure · as of Jun 30, 2026CallValue
$1,012,500
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. ANAB ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ANAB
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,012,500 | 15,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $54,493,830 | 807,316 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,375,199 | 475,572 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,441,922 | 813,571 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $46,518,746 | 1,519,230 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $309,261 | 10,100 | Call | Sole | 2025-11-14 | |
| 2025-09-16 | $27,681,724 | 1,426,893 | Shares | Sole | 2025-09-23 | |
| 2025-06-30 | $4,518,632 | 203,542 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $331,031 | 17,807 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,939,892 | 146,517 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,107,444 | 331,566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,366,494 | 373,762 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,573,222 | 647,125 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,718,604 | 407,031 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,014,035 | 446,217 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,078,824 | 397,189 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,660,071 | 260,113 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,003,633 | 322,802 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $715,607 | 28,052 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $614,804 | 30,286 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $627,273 | 18,051 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,599,068 | 132,709 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,787,998 | 107,520 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $491,341 | 22,800 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $1,526,388 | 70,995 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,250,404 | 288,164 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,607,675 | 116,727 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,126,078 | 221,237 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||